Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis

<div>Enrichment analysis of the KEGG pathway for upstream regulatory targets of L1CAM. The analyses are shown for ETS1 (a), FOL2 (b), and STAT1 (c).</div>

Disease Markers

fig3

Figure 3

Figure 3: Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis 

Figure 3 | Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis 